TY  - JOUR
TI  - Blood Purification Treatments in COVID-19
AB  - Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged for the first time in Wuhan, China,in December 2019. These viruses mainly cause respiratory and intestinal infections and induce a variety ofclinical manifestations (1, 2). High virus titer and the subsequent strong inflammatory cytokine and chemokineresponses are related to the high morbidity and mortality observed during the pathogenic HCoV infection.Blood purification system including plasma exchange, adsorption, perfusion, blood/plasma filtration, etc., canremove inflammatory factors, block the "cytokine storm", to reduce the damage of inflammatory responseto the body. This therapy can be used for severe and critical patients in the early and middle stages of thedisease (3). We recommend not using Extracorporeal treatments based on cytokine and / or endotoxin removalroutinely in patients infected with COVID-19 due to insufficient studies (4).
AU  - Temel, Şahin
AU  - Sungur, Murat
DO  - 10.37678/dcybd.2020.2436
PY  - 2020
JO  - Journal of critical and intensive care (Online)
VL  - 11
IS  - 1
SN  - 2717-6428
SP  - 32
EP  - 35
DB  - TRDizin
UR  - http://search/yayin/detay/384183
ER  -